NasdaqGM - Delayed Quote USD

Global X Genomics & Biotechnology ETF (GNOM)

9.80 +0.11 (+1.13%)
At close: April 26 at 4:00 PM EDT

Performance Overview: GNOM

Trailing returns as of 4/26/2024. Category is Health.

YTD Return

GNOM
15.21%
Category
6.33%

1-Year Return

GNOM
18.27%
Category
11.04%

3-Year Return

GNOM
25.38%
Category
0.38%

Trailing Returns (%) Vs. Benchmarks

Monthly Total Returns
GNOM
Category
YTD
-1.82%
6.33%
1-Month
-5.41%
1.19%
3-Month
-1.82%
6.33%
1-Year
-7.57%
11.04%
3-Year
-20.26%
-0.38%
5-Year
0.00%
7.51%
10-Year
0.00%
9.04%
Last Bull Market
0.00%
0.00%
Last Bear Market
0.00%
0.00%

Annual Total Return (%) History

Year
GNOM
Category
2023
-8.63%
3.22%
2022
-36.27%
-15.16%
2021
-15.93%
6.88%
2020
51.52%
27.63%

ETF Summary

The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.

ETF Overview

Category Health
Fund Family Global X Funds
Net Assets 103.57M
YTD Daily Total Return -15.21%
Yield 0.00%
Legal Type Exchange Traded Fund

Related Tickers